Assessment of Ceftazidime-Avibactam 30/20-μg Disk, Etest versus Broth Microdilution Results When Tested against <i>Enterobacterales</i> Clinical Isolates-Reference-Cited by-同舟云学术

Assessment of Ceftazidime-Avibactam 30/20-μg Disk, Etest versus Broth Microdilution Results When Tested against Enterobacterales Clinical Isolates

Published:2022-02-23 Issue:1 Volume:10 Page:
ISSN:2165-0497
Container-title:Microbiology Spectrum
language:en
Short-container-title:Microbiol Spectr

Author:

Han Renru¹²,Yang Xuelin¹³,Yang Yang¹²,Guo Yan¹²,Yin Dandan¹²,Ding Li¹²,Wu Shi¹²,Zhu Demei¹²,Hu Fupin¹²^ORCID

Affiliation:

1. Institute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, China

2. Key Laboratory of Clinical Pharmacology of Antibiotics, Ministry of Health, Shanghai, China

3. The Second People’s Hospital of Tibet Autonomous Region of China, Tibet, China

Abstract

Multidrug-resistant Gram-negative bacteria, especially for extended-spectrum β-lactamases-producing and carbapenemase-producing Enterobacterales , are disseminating rapidly around the world. Treatment options for these infections are limited, which prompt the development of novel or combinational therapies to combat the infections caused by multidrug-resistant pathogens.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Cell Biology,Microbiology (medical),Genetics,General Immunology and Microbiology,Ecology,Physiology

Link

https://journals.asm.org/doi/pdf/10.1128/spectrum.01092-21

Reference24 articles.

1. Enterobacteriaceae: joining the dots with pan-European epidemiology

2. Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomes

3. Ceftazidime-Avibactam: a Novel Cephalosporin/β-lactamase Inhibitor Combination

4. Results from the China Antimicrobial Surveillance Network (CHINET) in 2017 of the In Vitro Activities of Ceftazidime-Avibactam and Ceftolozane-Tazobactam against Clinical Isolates of Enterobacteriaceae and Pseudomonas aeruginosa

5. Dissemination of Carbapenemases (KPC, NDM, OXA-48, IMP, and VIM) Among Carbapenem-Resistant Enterobacteriaceae Isolated From Adult and Children Patients in China

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Double bla _KPC-2 copies quadrupled minimum inhibitory concentration of ceftazidime–avibactam in hospital-derived Klebsiella pneumoniae;Microbiology Spectrum;2024-08-06

2. Ceftazidime-Avibactam resistance in clinical isolates of carbapenem-resistant Klebsiella pneumoniae: A phenotypic and genotypic analysis;Indian Journal of Medical Microbiology;2024-05

3. Performance of disk diffusion method for aztreonam in combination with avibactam against Enterobacteriales;Journal of Antimicrobial Chemotherapy;2024-04-02

4. Approaches to Testing Novel β-Lactam and β-Lactam Combination Agents in the Clinical Laboratory;Antibiotics;2023-12-05

5. Resistotyping of Salmonella spp. and Staphylococcus aureus from Milk and Milk Products Sold in Sabon Gari and Zaria Local Government Areas in Kaduna State, Nigeria;ECA 2023;2023-11-30